Vaccine effectiveness against SARS-CoV-2 Delta and Omicron infection and infectiousness within households in the Netherlands between July 2021 and August 2022
Christina E. Hoeve, View ORCID ProfileBrechje de Gier, Anne J. Huiberts, Hester E. de Melker, Susan J.M. Hahné, Susan van den Hof, Mirjam J. Knol
doi: https://doi.org/10.1101/2023.01.10.23284386
Christina E. Hoeve
1Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands
Brechje de Gier
1Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands
Anne J. Huiberts
1Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands
Hester E. de Melker
1Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands
Susan J.M. Hahné
1Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands
Susan van den Hof
1Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands
Mirjam J. Knol
1Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
The data produced in this manuscript are available in aggregated and anonymized form upon reasonable request to the authors.
Posted January 11, 2023.
Vaccine effectiveness against SARS-CoV-2 Delta and Omicron infection and infectiousness within households in the Netherlands between July 2021 and August 2022
Christina E. Hoeve, Brechje de Gier, Anne J. Huiberts, Hester E. de Melker, Susan J.M. Hahné, Susan van den Hof, Mirjam J. Knol
medRxiv 2023.01.10.23284386; doi: https://doi.org/10.1101/2023.01.10.23284386
Vaccine effectiveness against SARS-CoV-2 Delta and Omicron infection and infectiousness within households in the Netherlands between July 2021 and August 2022
Christina E. Hoeve, Brechje de Gier, Anne J. Huiberts, Hester E. de Melker, Susan J.M. Hahné, Susan van den Hof, Mirjam J. Knol
medRxiv 2023.01.10.23284386; doi: https://doi.org/10.1101/2023.01.10.23284386
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2649)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12229)
- Forensic Medicine (10)
- Gastroenterology (760)
- Genetic and Genomic Medicine (4104)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2658)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (438)
- Neurology (3884)
- Nursing (209)
- Nutrition (578)
- Oncology (2033)
- Ophthalmology (585)
- Orthopedics (241)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6530)
- Radiology and Imaging (1405)
- Respiratory Medicine (871)
- Rheumatology (410)
- Sports Medicine (343)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)